Delivery Order SPE2DB22D3501-SPE2DB25FVP07
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,255.47 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on November 7, 2025, with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,364.04 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.54 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,237.02 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-spray units). This is a firm fixed-price, non-set-aside contract with a completion date of October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,591.90 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on July 16, 2025, with an ultimate completion date of July 17, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,507.14 for Naloxone HCL 4 mg nasal spray on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,572.48 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $8,603.40 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside, firm fixed-price contract represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion vehicle running through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Naloxone HCL 4 mg nasal spray (two-dose unit) valued at $1,397.76. The contract utilizes firm fixed pricing with a completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVP07Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,728.00 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on May 6, 2025, with completion due by May 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical supply requirement for the federal government's military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement facilitates the delivery of critical medical commodities, including specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 5/6/25 |